Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : RXSD Rexall Sundown -- Ignore unavailable to you. Want to Upgrade?

To: Dorine Essey who wrote (50)	8/4/1998 11:17:00 PM
From: john q	Read Replies (3) \| Respond to of 327

Don't worry Dorine, look for RXSD to rebound. Rexall doesn't compete with GNC in the malls. GNC is way overpriced and they dropped because they are overpriced and it will affect their bottom line. Rexall has done 375 million in sales so far thru 3 quarters and will probably go well over 500 million when the final numbers come out in september. When the street hears the RECORD numbers and RECORD earnings, we will rollercoaster right back up. You will probably be happy to have those shares at 22 3/8 and I just placed an order for some at 22 7/8. I have had RXSD for almost 5 years and I'm picking them to do over 550 million. Just my opinion...doc